Search Tag: Rewind Therapeutics

Executive Health Management

2022 19 Oct

Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated diseases announced that Irene Knuesel, PhD, PD, has been appointed as the Company´s Chief Scientific Officer. Irene Knuesel brings longstanding experience in CNS research, drug discovery and development. She is also a founder of Scienza Consulting GmbH,...Read more